MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
-
Published:2021-11-15
Issue:
Volume:
Page:
-
ISSN:0945-6317
-
Container-title:Virchows Archiv
-
language:en
-
Short-container-title:Virchows Arch
Author:
Kang Eun Young, Millstein Joshua, Popovic Gordana, Meagher Nicola S., Bolithon Adelyn, Talhouk Aline, Chiu Derek S., Anglesio Michael S., Leung Betty, Tang Katrina, Lambie Neil, Pavanello Marina, Da-anoy Annalyn, Lambrechts Diether, Loverix Liselore, Olbrecht Siel, Bisinotto Christiani, Garcia-Donas Jesus, Ruiz-Llorente Sergio, Yagüe-Fernandez Monica, Edwards Robert P., Elishaev Esther, Olawaiye Alexander, Taylor Sarah, Ataseven Beyhan, du Bois Andreas, Harter Philipp, Lester Jenny, Høgdall Claus K., Armasu Sebastian M., Huang Yajue, Vierkant Robert A., Wang Chen, Winham Stacey J., Heublein Sabine, Kommoss Felix K. F., Cramer Daniel W., Sasamoto Naoko, van-Wagensveld Lilian, Lycke Maria, Mateoiu Constantina, Joseph Janine, Pike Malcolm C., Odunsi Kunle, Tseng Chiu-Chen, Pearce Celeste L., Bilic Sanela, Conrads Thomas P., Hartmann Arndt, Hein Alexander, Jones Michael E., Leung Yee, Beckmann Matthias W., Ruebner Matthias, Schoemaker Minouk J., Terry Kathryn L., El-Bahrawy Mona A., Coulson Penny, Etter John L., LaVigne-Mager Katherine, Andress Juergen, Grube Marcel, Fischer Anna, Neudeck Nina, Robertson Greg, Farrell Rhonda, Barlow Ellen, Quinn Carmel, Hettiaratchi Anusha, Casablanca Yovanni, Erber Ramona, Stewart Colin J. R., Tan Adeline, Yu Yu, Boros Jessica, Brand Alison H., Harnett Paul R., Kennedy Catherine J., Nevins Nikilyn, Morgan Terry, Fasching Peter A., Vergote Ignace, Swerdlow Anthony J., Candido dos Reis Francisco J., Maxwell G. Larry, Neuhausen Susan L., Barquin-Garcia Arantzazu, Modugno Francesmary, Moysich Kirsten B., Crowe Philip J., Hirasawa Akira, Heitz Florian, Karlan Beth Y., Goode Ellen L., Sinn Peter, Horlings Hugo M., Høgdall Estrid, Sundfeldt Karin, Kommoss Stefan, Staebler Annette, Wu Anna H., Cohen Paul A., DeFazio Anna, Lee Cheng-Han, Steed Helen, Le Nhu D., Gayther Simon A., Lawrenson Kate, Pharoah Paul D. P., Konecny Gottfried, Cook Linda S., Ramus Susan J., Kelemen Linda E., Köbel MartinORCID
Funder
Alberta Precision Laboratories National Cancer Institute Medical Research and Materiel Command National Center for Research Resources Westmead Hospital Department of Gynaecological Oncology National Health and Medical Research Council Cancer Institute NSW Sydney West Translational Cancer Research Centre Breast Cancer Now Institute of Cancer Research Swedish Cancer Foundation U.S. Defense Health Program BC Cancer Foundation VGH and UBC Hospital Foundation Michael Smith Foundation for Health Research Heuer Stiftung für medizinische Forschung University of Pittsburgh Dean's Faculty Advancement Fund American Cancer Society ALF-agreement Assar Gabrielsson Foundation NSW Ministry of Health University of New South Wales Translational Cancer Research Network Dutch Cancer Society
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference44 articles.
1. Peres LC, Cushing-Haugen KL, Kobel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA (2019) Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst 111:60–68. https://doi.org/10.1093/jnci/djy071 2. Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, Leong HS, Chen S, Intermaggio MP, Gilks B, Nazeran TM, Volchek M, Elatre W, Bentley RC, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, Leong SCY, Liu G, Johnson D, Chen B, Group A, Alsop J, Banerjee SN, Behrens S, Bodelon C, Brand AH, Brinton L, Carney ME, Chiew YE, Cushing-Haugen KL, Cybulski C, Ennis D, Fereday S, Fortner RT, García-Donas J, Gentry-Maharaj A, Glasspool R, Goranova T, Greene CS, Haluska P, Harris HR, Hendley J, Hernandez BY, Herpel E, Jimenez-Linan M, Karpinskyj C, Kaufmann SH, Keeney GL, Kennedy CJ, Köbel M, Koziak JM, Larson MC, Lester J, Lewsley LA, Lissowska J, Lubiński J, Luk H, Macintyre G, Mahner S, McNeish IA, Menkiszak J, Nevins N, Osorio A, Oszurek O, Palacios J, Hinsley S, Pearce CL, Pike MC, Piskorz AM, Ray-Coquard I, Rhenius V, Rodriguez-Antona C, Sharma R, Sherman ME, De Silva D, Singh N, Sinn P, Slamon D, Song H, Steed H, Stronach EA, Thompson PJ, Tołoczko A, Trabert B, Traficante N, Tseng CC, Widschwendter M, Wilkens LR, Winham SJ, Winterhoff B, Beeghly-Fadiel A, Benitez J, Berchuck A, Brenton JD, Brown R, Chang-Claude J, Chenevix-Trench G, deFazio A, Fasching PA, García MJ, Gayther SA, Goodman MT, Gronwald J, Henderson MJ, Karlan BY, Kelemen LE, Menon U, Orsulic S, Pharoah PDP, Wentzensen N, Wu AH, Schildkraut JM, Rossing MA, Konecny GE, Huntsman DG, Huang RY, Goode EL, Ramus SJ, Doherty JA, Bowtell DD, Anglesio MS (2020) Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE). Clin Cancer Res 26:5411–5423. https://doi.org/10.1158/1078-0432.Ccr-20-0103 3. Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benítez J, García MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans DG, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lázaro C, Blanco I, Montagna M, D’Andrea E, Nicoletto MO, Johnatty SE, Kjær SK, Jensen A, Høgdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg Å, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD (2012) Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA 307:382–390. https://doi.org/10.1001/jama.2012.20 4. Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PDP, Goode EL, Huntsman DG, Ramus SJ (2013) Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol 14:853–862. https://doi.org/10.1016/s1470-2045(13)70253-5 5. Chan AM, Enwere E, McIntyre JB, Wilson H, Nwaroh C, Wiebe N, Ou Y, Liu S, Wiedemeyer K, Rambau PF, Grevers X, Morris DG, Neri P, Gilks CB, Visser F, Le N, Luo L, Cook LS, Kobel M (2020) Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma. J Pathol Clin Res 6:252–262. https://doi.org/10.1002/cjp2.168
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|